期刊文献+

股静脉半永久双腔导管在维持性透析患者中的临床应用 被引量:3

The clinical application of semi-permanent femoral vein double-lumen catheter in maintaining dialysis patients
暂未订购
导出
摘要 目的探讨股静脉半永久留置导管在维持行透析(MHD)患者中的临床应用。方法将10例行股静脉半永久双腔导管留置的患者,与同期颈内静脉双腔导管留置患者52例做对比,观察两组患者的导管使用寿命、并发症、透析血流量及透析充分性等指标。结果股静脉组留置时间>6个月者为70.0%(7/10),颈内静脉留置时间>6月者为86.5%(45/52);两组间导管感染和导管功能不良等并发症方面并无明显统计学差异(P>0.05);导管血流量和透析充分性在两组间亦无明显统计学差异(P>0.05)。结论在血管条件不佳或一般情况较差、留置颈内静脉困难的透析患者中,股静脉留置半永久性导管亦可以是一种较为理想的选择。 Objective Discussion the clinical application of the semi-permanent double-lumen vein cuffed-tunneled catheters in maintaining hemodialysis (MHD) patients. Methods 10 cuffed- ttmeled catheters were indwelled in femoral vein as femoral vein group and the other 52 catheters were indwelled in internal jugular vein as jugular vein group in the same period.The catheter survival time,related complications of catheters,mean blood flow during hemodialysis and Kt/V in the two groups were observed. Results There was 70.0%(7/10) catheters sustainable using over 6 months in femoral vein group, while 86.5%(45/52) catheters in jugular vein group. There were no significant differences between the two groups in catheter infection and catheter dysfimction aspects (P〉0.05). Catheter blood flow and dialysis adequacy also have no significant differences between the two groups (P〉0.05). Conclusions Semi-permanent femoral vein double-lumen catheter can also be an ideal choice, when the patients have poor vascular conditions or poor general conditions,or have difficult to be indwelled internal jugular vein catheter.
出处 《中国血液净化》 2014年第11期797-799,共3页 Chinese Journal of Blood Purification
关键词 股静脉 半永久双腔导管 血液透析 femoral vein Semi-permanent dual-lumen catheter hemodialysis
  • 相关文献

参考文献15

  • 1Moist LM, Trpeski L, Na Y, et al. Increased Hemodialy- sis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Regis- try 2001-2004[J]. Clin J Am Soc Nephrol. 2008;3: 1726- 1732.
  • 2陈枫,樊勇,梁莉,黄云剑,袁发焕.双腔带涤纶套长期留置管在血液透析中的应用[J].中日友好医院学报,2010,24(1):55-56. 被引量:5
  • 3叶朝阳,戴兵.更新版血液透析血管通路临床实践指南解读[J].中国血液净化,2009,8(6):331-334. 被引量:46
  • 4Bakir T, Donna C, Souheil S, et al. Bacertemia associated with tunneled dialysis catheters. Comparison of two treatment strategies [J].KidneyInt, 2000,57:2151.
  • 5Quarello F, Forneris G, Borca M, et al. Do central venous catheters have advantages over arteriovenous fistulas or grafts[J]. J Nephrol, 2006,19: 265-279.
  • 6Taal MW, Fluck RJ, Mcintyre CW. Preventing catheter relat- ed infections in hemodialysis patients [J].Curr Opin Nephrol Hypertens, 2006,15: 599-602.
  • 7Perl J, Wald R, McFarlane P, et al. Hemodialysis vaseu- lar access modifies the association between dialysis modality and survival[J]. J Am Sac Nephrol. 2011;22: 1113-1121.
  • 8蒋娟.颈内静脉留置永久导管血透并发感染临床分析[J].实用诊断与治疗杂志,2006,20(1):49-51. 被引量:12
  • 9Brenda RB, Louise MM, Charmaine EL, et al. Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator[J].The New England Journal of Medicine, 2011,364:303-312.
  • 10Tan HK, Yang WS, Chow P. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular ad -- sorbent recirculating system [J]. Artif Organs, 2007,31:193- 199.

二级参考文献20

共引文献65

同被引文献27

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部